Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 244

1.

The combined activation of KCa3.1 and inhibition of Kv11.1/hERG1 currents contribute to overcome Cisplatin resistance in colorectal cancer cells.

Pillozzi S, D'Amico M, Bartoli G, Gasparoli L, Petroni G, Crociani O, Marzo T, Guerriero A, Messori L, Severi M, Udisti R, Wulff H, Chandy KG, Becchetti A, Arcangeli A.

Br J Cancer. 2018 Jan;118(2):200-212. doi: 10.1038/bjc.2017.392. Epub 2017 Nov 21.

2.

Circulating Endothelial Progenitor Cells in Type 1 Diabetic Patients: Relation with Patients' Age and Disease Duration.

Arcangeli A, Lastraioli E, Piccini B, D'Amico M, Lenzi L, Pillozzi S, Calabrese M, Toni S, Arcangeli A.

Front Endocrinol (Lausanne). 2017 Oct 23;8:278. doi: 10.3389/fendo.2017.00278. eCollection 2017.

3.

Auranofin, Et3PAuCl, and Et3PAuI Are Highly Cytotoxic on Colorectal Cancer Cells: A Chemical and Biological Study.

Marzo T, Cirri D, Gabbiani C, Gamberi T, Magherini F, Pratesi A, Guerri A, Biver T, Binacchi F, Stefanini M, Arcangeli A, Messori L.

ACS Med Chem Lett. 2017 Sep 6;8(10):997-1001. doi: 10.1021/acsmedchemlett.7b00162. eCollection 2017 Oct 12.

PMID:
29057040
4.

Amount, composition, and spatial distribution of floating macro litter along fixed trans-border transects in the Mediterranean basin.

Arcangeli A, Campana I, Angeletti D, Atzori F, Azzolin M, Carosso L, Di Miccoli V, Giacoletti A, Gregorietti M, Luperini C, Paraboschi M, Pellegrino G, Ramazio M, SarĂ  G, Crosti R.

Mar Pollut Bull. 2017 Oct 16. pii: S0025-326X(17)30861-5. doi: 10.1016/j.marpolbul.2017.10.028. [Epub ahead of print]

PMID:
29042107
5.

Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial.

Vaccaro O, Masulli M, Nicolucci A, Bonora E, Del Prato S, Maggioni AP, Rivellese AA, Squatrito S, Giorda CB, Sesti G, Mocarelli P, Lucisano G, Sacco M, Signorini S, Cappellini F, Perriello G, Babini AC, Lapolla A, Gregori G, Giordano C, Corsi L, Buzzetti R, Clemente G, Di Cianni G, Iannarelli R, Cordera R, La Macchia O, Zamboni C, Scaranna C, Boemi M, Iovine C, Lauro D, Leotta S, Dall'Aglio E, Cannarsa E, Tonutti L, Pugliese G, Bossi AC, Anichini R, Dotta F, Di Benedetto A, Citro G, Antenucci D, Ricci L, Giorgino F, Santini C, Gnasso A, De Cosmo S, Zavaroni D, Vedovato M, Consoli A, Calabrese M, di Bartolo P, Fornengo P, Riccardi G; Thiazolidinediones Or Sulfonylureas Cardiovascular Accidents Intervention Trial (TOSCA.IT) study group; Italian Diabetes Society.

Lancet Diabetes Endocrinol. 2017 Nov;5(11):887-897. doi: 10.1016/S2213-8587(17)30317-0. Epub 2017 Sep 13.

PMID:
28917544
6.

A spatially explicit risk assessment approach: Cetaceans and marine traffic in the Pelagos Sanctuary (Mediterranean Sea).

Pennino MG, Arcangeli A, Prado Fonseca V, Campana I, Pierce GJ, Rotta A, Bellido JM.

PLoS One. 2017 Jun 23;12(6):e0179686. doi: 10.1371/journal.pone.0179686. eCollection 2017.

7.

A novel microfluidic 3D platform for culturing pancreatic ductal adenocarcinoma cells: comparison with in vitro cultures and in vivo xenografts.

Beer M, Kuppalu N, Stefanini M, Becker H, Schulz I, Manoli S, Schuette J, Schmees C, Casazza A, Stelzle M, Arcangeli A.

Sci Rep. 2017 Apr 25;7(1):1325. doi: 10.1038/s41598-017-01256-8.

8.

The conformational state of hERG1 channels determines integrin association, downstream signaling, and cancer progression.

Becchetti A, Crescioli S, Zanieri F, Petroni G, Mercatelli R, Coppola S, Gasparoli L, D'Amico M, Pillozzi S, Crociani O, Stefanini M, Fiore A, Carraresi L, Morello V, Manoli S, Brizzi MF, Ricci D, Rinaldi M, Masi A, Schmidt T, Quercioli F, Defilippi P, Arcangeli A.

Sci Signal. 2017 Apr 4;10(473). pii: eaaf3236. doi: 10.1126/scisignal.aaf3236.

PMID:
28377405
9.

PtI2(DACH), the iodido analogue of oxaliplatin as a candidate for colorectal cancer treatment: chemical and biological features.

Cirri D, Pillozzi S, Gabbiani C, Tricomi J, Bartoli G, Stefanini M, Michelucci E, Arcangeli A, Messori L, Marzo T.

Dalton Trans. 2017 Mar 7;46(10):3311-3317. doi: 10.1039/c6dt03867k.

PMID:
28229139
10.

Seasonal characterisation of maritime traffic and the relationship with cetacean presence in the Western Mediterranean Sea.

Campana I, Angeletti D, Crosti R, Luperini C, Ruvolo A, Alessandrini A, Arcangeli A.

Mar Pollut Bull. 2017 Feb 15;115(1-2):282-291. doi: 10.1016/j.marpolbul.2016.12.008. Epub 2016 Dec 18.

PMID:
27993370
11.

hERG Channels: From Antitargets to Novel Targets for Cancer Therapy.

Arcangeli A, Becchetti A.

Clin Cancer Res. 2017 Jan 1;23(1):3-5. doi: 10.1158/1078-0432.CCR-16-2322. Epub 2016 Nov 30.

12.

hERG1 positivity and Glut-1 negativity identifies high-risk TNM stage I and II colorectal cancer patients, regardless of adjuvant chemotherapy.

Muratori L, Petroni G, Antonuzzo L, Boni L, Iorio J, Lastraioli E, Bartoli G, Messerini L, Di Costanzo F, Arcangeli A.

Onco Targets Ther. 2016 Oct 14;9:6325-6332. eCollection 2016.

13.

LH/hCG-Receptor Expression May Have a Negative Prognostic Value in Low-Risk Endometrial Cancer.

Noci I, Sorbi F, Mannini L, Projetto E, Pillozzi S, Ghizzoni V, Lottini T, Moncini D, Baroni G, Mungai F, Arcangeli A, Fambrini M.

Front Oncol. 2016 Aug 25;6:190. doi: 10.3389/fonc.2016.00190. eCollection 2016.

14.

Thermal noise and optomechanical features in the emission of a membrane-coupled compound cavity laser diode.

Baldacci L, Pitanti A, Masini L, Arcangeli A, Colangelo F, Navarro-Urrios D, Tredicucci A.

Sci Rep. 2016 Aug 19;6:31489. doi: 10.1038/srep31489.

15.

hERG1 behaves as biomarker of progression to adenocarcinoma in Barrett's esophagus and can be exploited for a novel endoscopic surveillance.

Lastraioli E, Lottini T, Iorio J, Freschi G, Fazi M, Duranti C, Carraresi L, Messerini L, Taddei A, Ringressi MN, Salemme M, Villanacci V, Vindigni C, Tomezzoli A, La Mendola R, Bencivenga M, Compagnoni B, Chiudinelli M, Saragoni L, Manzi I, De Manzoni G, Bechi P, Boni L, Arcangeli A.

Oncotarget. 2016 Sep 13;7(37):59535-59547. doi: 10.18632/oncotarget.11149.

16.

Gate-Tunable Spatial Modulation of Localized Plasmon Resonances.

Arcangeli A, Rossella F, Tomadin A, Xu J, Ercolani D, Sorba L, Beltram F, Tredicucci A, Polini M, Roddaro S.

Nano Lett. 2016 Sep 14;16(9):5688-93. doi: 10.1021/acs.nanolett.6b02351. Epub 2016 Aug 8.

PMID:
27479039
17.

Macrolide antibiotics exert antileukemic effects by modulating the autophagic flux through inhibition of hERG1 potassium channels.

Pillozzi S, Masselli M, Gasparoli L, D'Amico M, Polletta L, Veltroni M, Favre C, Basso G, Becchetti A, Arcangeli A.

Blood Cancer J. 2016 May 13;6:e423. doi: 10.1038/bcj.2016.32. No abstract available.

18.

Cisplatin and its dibromido analogue: a comparison of chemical and biological profiles.

Marzo T, Bartoli G, Gabbiani C, Pescitelli G, Severi M, Pillozzi S, Michelucci E, Fiorini B, Arcangeli A, Quiroga AG, Messori L.

Biometals. 2016 Jun;29(3):535-42. doi: 10.1007/s10534-016-9934-4. Epub 2016 Apr 16.

PMID:
27086032
19.

Water-soluble Ru(II)- and Ru(III)-halide-PTA complexes (PTA=1,3,5-triaza-7-phosphaadamantane): Chemical and biological properties.

Battistin F, Scaletti F, Balducci G, Pillozzi S, Arcangeli A, Messori L, Alessio E.

J Inorg Biochem. 2016 Jul;160:180-8. doi: 10.1016/j.jinorgbio.2016.02.009. Epub 2016 Feb 16.

PMID:
26920229
20.

Tumor-selective peptide-carrier delivery of Paclitaxel increases in vivo activity of the drug.

Brunetti J, Pillozzi S, Falciani C, Depau L, Tenori E, Scali S, Lozzi L, Pini A, Arcangeli A, Menichetti S, Bracci L.

Sci Rep. 2015 Dec 2;5:17736. doi: 10.1038/srep17736.

Supplemental Content

Loading ...
Support Center